Medline INC Form 4 insider transactions

Carlyle-affiliated entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Hellman & Friedman entities converted over 15 million Medline Common Units into Class A Common Stock, leading to the cancellation of an equivalent number of Class B shares.

Medline Inc.'s Chief Commercial Officer, Douglas P. Golwas, reported significant acquisitions of Class B Common Stock, Common Units, and Incentive Units related to the company's IPO reclassification, alongside a new grant of restricted stock units.

Medline Executive Vice President William J. Abrams reported the reclassification of equity interests and a new restricted stock unit grant, primarily linked to the company's IPO.

Medline Inc. CEO James M. Boyle reported substantial acquisitions of Class B and Class A Common Stock, along with various incentive units, primarily linked to reclassification and RSU grants.

CP Circle Holdings, L.P. has transferred all its beneficial ownership in Medline Inc. securities to an affiliated entity.

Carlyle Mozart Coinvestment Holdings, L.P. reported a transfer of over 15 million Class A Common Stock shares of Medline Inc. to an affiliated entity for no consideration.